Global Star Acquisition Inc. - Quarter Report: 2022 September (Form 10-Q)
Table of Contents
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
❑ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware |
84-2508938 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) |
Ang, Anthony |
22102 | |
(Address of principal executive offices) |
(Zip Code) |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Units, each consisting of one share of Class A common Stock and one Redeemable Warrant |
GLSTU |
The Nasdaq Stock Market LLC | ||
Class A Common Stock, $0.0001 par value per share |
GLST |
The Nasdaq Stock Market LLC | ||
Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per shar |
GLSTW |
The Nasdaq Stock Market LLC | ||
Rights, exchangeable into one-tenth of one share of Class A common stock |
GLSTUR |
The Nasdaq Stock Market LLC |
Table of Contents
GLOBAL STAR ACQUISITION CORP.
TABLE OF CONTENTS
2
Table of Contents
September 30, 2022 |
December 31, 2021 |
|||||||
(unaudited) |
||||||||
ASSETS |
||||||||
Current Assets: |
||||||||
Cash |
$ | 1,397,490 | $ | — | ||||
Due from Sponsor |
10,530 | 25,000 | ||||||
Prepaid expenses |
10,000 | 25,071 | ||||||
Other current assets |
263,473 | — | ||||||
|
|
|
|
|||||
Total Current Assets |
1,681,493 | 50,071 | ||||||
Investments held in the Trust Account |
82,043,907 | — | ||||||
Deferred offering costs |
— | 31,000 | ||||||
Other assets |
103,580 | — | ||||||
|
|
|
|
|||||
Total Assets |
$ |
83,828,980 |
$ |
81,071 |
||||
|
|
|
|
|||||
LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ (DEFICIT) EQUITY |
||||||||
Current Liabilities: |
||||||||
Accounts payable and accrued expenses |
$ | 456,833 | $ | — | ||||
Accrued offering costs |
55,349 | 15,000 | ||||||
Accrued franchise tax payable |
150,637 | 1,596 | ||||||
Advances from related party |
— | 42,384 | ||||||
Due to related party |
112,250 | — | ||||||
Overallotment liability |
44,975 | — | ||||||
|
|
|
|
|||||
Total Current Liabilities |
820,044 | 58,980 | ||||||
Deferred underwriting commission |
2,800,000 | — | ||||||
|
|
|
|
|||||
Total liabilities |
3,620,044 | 58,980 | ||||||
COMMITMENTS AND CONTINGENCIES (Note 6) |
||||||||
Class A common stock subject to possible redemption; 8,000,000 shares (at $10.25 per share) |
82,000,000 | — | ||||||
Stockholders’ ( deficit) equity : |
||||||||
Preferred Stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding |
— | — | ||||||
Class A common stock, $0.0001 par value, 100,000,000 shares authorized, 556,225 shares issued and outstanding (excluding 8,000,000 shares subject to possible redemption) |
56 | — | ||||||
Class B common stock, $0.0001 par value, 10,000,000 shares authorized, 2,300,000 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively (1)(2)(3) |
230 | 230 | ||||||
Additional paid-in capital |
— | 24,770 | ||||||
Accumulated deficit |
(1,791,350 | ) | (2,909 | ) | ||||
|
|
|
|
|||||
Total Stockholders’ (Deficit) Equity |
(1,791,064 | ) | 22,091 | |||||
|
|
|
|
|||||
Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders’ (Deficit) Equity |
$ |
83,828,980 |
$ |
81,071 |
||||
|
|
|
|
(1) | Includes an aggregate of up to 300,000 shares of Class B common stock subject to forfeiture if the over- allotment option is not exercised in full or in part by the underwriters (see Note 5). |
(2) | Shares and the associated amounts have been retroactively restated to account for the share issuance in February 14, 2022 as discussed in Note 5. |
(3) | On July 26, 2022, the Sponsor surrendered and forfeited 575,000 founder shares for no consideration following which the Sponsor holds 2,300,000 founder shares. All share amounts have been retroactively restated to reflect this surrender as discussed in Note 5. |
For the Three Months Ended September 30, |
For the Nine Months Ended September 30, |
|||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
EXPENSES |
||||||||||||||||
Administration fee—related party |
$ | 3,666 | $ | — | $ | 3,666 | $ | — | ||||||||
General and administrative |
257,030 | 19 | 257,763 | 78 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
TOTAL EXPENSES |
260,696 | 19 | 261,429 | 78 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
OTHER INCOME (EXPENSE) |
||||||||||||||||
Income earned on Investments held in Trust Account |
43,907 | — | 43,907 | — | ||||||||||||
Interest income |
126 | — | 153 | — |
||||||||||||
Change in fair value of overallotment liability |
7,619 | — | 7,619 | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
TOTAL OTHER INCOME |
51,652 | — | 51,679 | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss |
$ |
(209,044 | ) | $ |
(19 | ) | $ |
(209,750 | ) | $ |
(78 | ) | ||||
|
|
|
|
|
|
|
|
|||||||||
Weighted average number of shares of Class A common stock outstanding, basic and diluted |
704,348 | — | 237,363 | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net loss per share of Class A common stock |
$ | (0.08 | ) | $ | — | $ | (0.09 | ) | $ | — | ||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted average number of shares of Class B common stock outstanding, basic and diluted (1)(2)(3) |
2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net loss per share of Class B common stock |
$ | (0.08 | ) | $ | (0.00 | ) | $ | (0.09 | ) | $ | (0.00 | ) | ||||
|
|
|
|
|
|
|
|
(1) | Excludes an aggregate of up to 300,000 shares of Class B common stock subject to forfeiture if the over- allotment option is not exercised in full or in part by the underwriters (see Note 5). |
(2) | Shares and the associated amounts have been retroactively restated to account for the share issuance in February 14, 2022 as discussed in Note 5. |
(3) | On July 26, 2022, the Sponsor surrendered and forfeited 575,000 founder shares for no consideration following which the Sponsor holds 2,300,000 founder shares. All share amounts have been retroactively restated to reflect this surrender as discussed in Note 5. |
Class A |
Class B |
Additional |
||||||||||||||||||||||||||
Common Stock |
Common Stock (1)(2)(3) |
Paid-In |
Accumulated |
Stockholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Equity (Deficit) |
||||||||||||||||||||||
Balance as of January 1, 2022 | — | $ | — | 2,300,000 | $ | 230 | $ | 24,770 | $ | (2,909) | $ | 22,091 | ||||||||||||||||
Net loss | — | — | — | — | — | (708 | ) | (708 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance as of March 31, 2022 | — | — | 2,300,000 | 230 | 24,770 | (3,617 | ) | 21,383 | ||||||||||||||||||||
Net income | — | — | — | — | — | 2 | 2 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance as of June 30, 2022 | — | — | 2,300,000 | 230 | 24,770 | (3,615 | ) | 2,385 | ||||||||||||||||||||
Sale of Units in Public Offering, net of offering costs | — | — | — | — | 379,243 | — | 379,243 | |||||||||||||||||||||
Proceeds from Private Placement Units, net of offering costs |
456,225 | 46 | — | — | 4,535,229 | — | 4,535,275 | |||||||||||||||||||||
Proceeds from Sale of Rights, net of costs | — | — | — | — | 53,094 | — | 53,094 | |||||||||||||||||||||
Class A common stock issued to representative | 100,000 | 10 | — | — | 68,990 | — | 69,000 | |||||||||||||||||||||
Remeasurement adjustment of Class A ordinary shares to redemption value | — | — | — | — | (5,061,326 | ) | (1,578,691 | ) | (6,640,017 | ) | ||||||||||||||||||
Net loss | — | — | — | — | — | (209,044 | ) | (209,044 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance as of September 30, 2022 |
556,225 | $ | 56 | 2,300,000 | $ | 230 | $ | — | $ | (1,791,350 | ) | $ | (1,791,064 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class B Common Stock (1)(2)(3) |
Additional Paid-In |
Accumulated Deficit |
Stockholders’ Equity |
|||||||||||||||||
Shares |
Amount |
Capital |
||||||||||||||||||
Balance as of January 1, 2021 |
2,300,000 | $ | 230 | $ | 24,770 | $ | (1,210 | ) | $ | 23,790 | ||||||||||
Net loss |
— | — | — | (59 | ) | (59 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of March 31, 2021 |
2,300,000 | 230 | 24,770 | (1,269 | ) | 23,731 | ||||||||||||||
Net loss |
— | — | — | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of June 30, 2021 |
2,300,000 | 230 | 24,770 | (1,269 | ) | 23,731 | ||||||||||||||
Net loss |
— | — | — | (19 | ) | (19 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of September 30, 2021 |
2,300,000 | $ | 230 | $ | 24,770 | $ | (1,288 | ) | $ | 23,712 | ||||||||||
|
|
|
|
|
|
|
|
|
|
(1) | Includes an aggregate of up to 300,000 shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5). |
(2) | Shares and the associated amounts have been retroactively restated to account for the share issuance in February 14, 2022 as discussed in Note 5. |
(3) | On July 26, 2022, the Sponsor surrendered and forfeited 575,000 founder shares for no consideration following which the Sponsor holds 2,300,000 founder shares. All share amounts have been retroactively restated to reflect this surrender as discussed in Note 5. |
For the Nine Months Ended September 30, |
||||||||
2022 |
2021 |
|||||||
Cash Flows From Operating Activities: |
||||||||
Net loss |
$ | (209,750 | ) | $ | (78 | ) | ||
Adjustments to reconcile net income (loss) to net cash used in operating activities: |
||||||||
Formation and organization costs paid by related parties |
||||||||
Income earned on Investments held in Trust Account |
(43,907 | ) | — | |||||
Change in fair value of overallotment liability |
(7,619 | ) | — | |||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
15,071 | (71 | ) | |||||
Other current assets |
(263,473 | ) | ||||||
Other assets |
(103,580 | ) | — | |||||
Accounts payable and accrued expenses |
456,833 | (507 | ) | |||||
Accrued franchise tax payable |
149,041 | — | ||||||
Advances from related party |
(42,384 | ) | 656 | |||||
|
|
|
|
|||||
Net Cash Provided By Operating Activities |
(49,768 | ) | — | |||||
Cash Flows From Investing Activities: |
||||||||
Cash deposited into Trust Account |
(82,000,000 | ) | — | |||||
|
|
|
|
|||||
Net Cash Used In Investing Activities |
(82,000,000 | ) | — | |||||
Cash Flows From Financing Activities: |
||||||||
Proceeds from sale of Units in Public Offering, net of underwriting fee |
79,200,000 | — | ||||||
Proceeds from sale of Private Placement Warrants |
4,563,000 | — | ||||||
Proceeds from note payable |
185,000 | — | ||||||
Repayment of note payable |
(185,000 | ) | — | |||||
Proceeds from Due from Sponsor |
25,000 | — | ||||||
Due to related party |
112,500 | — | ||||||
Due from Sponsor |
(10,530 | ) | — | |||||
Payment of offering costs |
(442,462 | ) | — | |||||
|
|
|
|
|||||
Net Cash Provided By Financing Activities |
83,447,258 | — | ||||||
|
|
|
|
|||||
Net change in cash |
1,397,490 | — | ||||||
Cash at beginning of period |
— | — | ||||||
|
|
|
|
|||||
Cash at end of period |
$ | 1,397,490 | $ | — | ||||
Supplemental disclosure of non-cash financing activities: |
||||||||
Offering costs included in accrued offering costs |
$ | 40,349 | $ | — | ||||
Deferred underwriters’ commission |
$ | 2,800,000 | $ | — | ||||
Class A ordinary shares remeasurement adjustment |
$ | 6,640,017 | $ | — | ||||
Fair value of over-allotment option at issuance |
$ | 52,594 | $ | — |
Gross proceeds |
$ | 80,000,000 | ||
Less: |
||||
Transaction costs allocated to Class A common stock |
(4,184,017 | ) | ||
Proceeds allocated to Public Rights and Warrants |
(456,000 | ) | ||
|
|
|||
(4,640,017 | ) | |||
Plus: Remeasurement adjustment of Class A ordinary shares to redemption value |
6,640,017 | |||
|
|
|||
Class A common stock subject to possible redemption |
$ | 82,000,000 | ||
|
|
Three Months Ended |
Three Months Ended |
|||||||||||||||
September 30, 2022 |
September 30, 2021 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Numerator: Basic and diluted net loss per share of common stock |
||||||||||||||||
Allocation of net loss, as adjusted |
$ | (54,446 | ) | $ | (154,598 | ) | — | $ | (19 | ) | ||||||
Denominator: Basic and diluted weighted average shares outstanding |
704,348 | 2,000,000 | — | 2,000,000 | ||||||||||||
Basic and diluted net loss per share of common stock |
$ | (0.08 | ) | $ | (0.08 | ) | (0.00 | ) | $ | (0.00 | ) |
Nine Months Ended |
Nine Months Ended |
|||||||||||||||
September 30, 2022 |
September 30, 2021 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Numerator: Basic and diluted net loss per share of common stock |
||||||||||||||||
Allocation of net loss, as adjusted |
$ | (22,252 | ) | $ | (187,498 | ) | — | $ | (78 | ) | ||||||
Denominator: Basic and diluted weighted average shares outstanding |
237,363 | 2,000,000 | — | 2,000,000 | ||||||||||||
Basic and diluted net loss per share of common stock |
$ | (0.09 | ) | $ | (0.09 | ) | (0.00 | ) | $ | (0.00 | ) |
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
• |
in whole and not in part; |
• |
at a price of $ 0.01 per Public Warrant; |
• | upon a minimum of 30 days’ prior written notice of redemption, or the 30 -day redemption period to each warrant holder; and |
• | if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganization, recapitalizations and the like) for any 20 trading days within a 30 -trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to warrant holders. |
Description |
Level |
September 30, 2022 |
||||||
Assets: |
||||||||
Cash in the Trust Account |
1 |
$ |
82,403,907 |
|||||
Liabilities: |
||||||||
Overallotment Option |
3 |
$ |
44,975 |
September 22, 2022 |
September 30, 202 2 |
|||||||
Risk-free interest rate |
2.96 |
% |
2.96 |
% | ||||
Expected life of warrants |
0.12 years |
0.10 years |
||||||
Expected volatility of underlying shares |
1.5 |
% |
1.5 |
% | ||||
Dividend yield |
0 |
% |
0 |
% |
Overallotment Liability |
||||
Fair value at January 1, 2022 |
$ |
— |
||
Initial measurement at September 22, 2022 |
52,594 |
|||
Change in fair value |
(7,619 |
) | ||
Fair value at September 30, 2022 |
$ |
44,975 |
||
Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
References to the “Company,” “us,” “our” or “we” refer to Global Star Acquisition Corp. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited financial statements and related notes included herein.
Cautionary Note Regarding Forward-Looking Statements
All statements other than statements of historical fact included in this Form 10-Q including, without limitation, statements under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward- looking statements. When used in this Form 10-Q, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or the Company’s management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on the Company’s behalf are qualified in their entirety by this paragraph.
Overview
The Company is a blank check company formed under the laws of the State of Delaware on July 24, 2019, for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to effectuate its initial Business Combination using cash from the proceeds of Public Offering and the Private Placement, the proceeds of the sale of our securities in connection with our initial Business Combination, our shares, debt or a combination of cash, stock and debt.
The issuance of additional shares in connection with an initial Business Combination to the owners of the target or other investors:
• | may significantly dilute the equity interest of investors, which dilution would increase if the anti-dilution provisions in the Class B common stock resulted in the issuance of Class A common stock on a greater than one -to-one basis upon conversion of the Class B common stock; |
• | may subordinate the rights of holders of our common stock if preferred stock is issued with rights senior to those afforded our common stock; |
• | could cause a change in control if a substantial number of shares of our common stock is issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; |
• | may have the effect of delaying or preventing a change of control of us by diluting the stock ownership or voting rights of a person seeking to obtain control of us; and |
• | may adversely affect prevailing market prices for our Class A common stock and/or warrants. |
19
Table of Contents
Similarly, if we issue debt securities or otherwise incur significant debt to bank or other lenders or the owners of a target, it could result in:
• | default and foreclosure on our assets if our operating revenues after an initial Business Combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand; |
• | our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding; |
• | our inability to pay dividends on our common stock; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our common stock if declared, our ability to pay expenses, make capital expenditures and acquisitions, and fund other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, and execution of our strategy; and |
• | other purposes and other disadvantages compared to our competitors who have less debt. |
We expect to continue to incur significant costs in the pursuit of our initial Business Combination plans. We cannot assure you that our plans to raise capital or to complete our initial Business Combination will be successful.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities from inception to September 30, 2022 were organizational activities, those necessary to prepare for the Initial Public Offering (“Initial Public Offering”) and identifying a target company for a business combination. We do not expect to generate any operating revenues until after the completion of our business combination. We expect to generate non-operating income in the form of interest income on cash and marketable securities held after the Initial Public Offering. We expect that we will incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with completing a business combination.
20
Table of Contents
For the three months ended September 30, 2022, we had a net loss of $209,044, which consists of interest income from marketable securities held in the Trust Account of $43,907 and a gain on the change in fair value of the overallotment option of $7,619 offset by operating costs of $260,696. In addition, the Company recorded an income tax provision of $9,243. For the three months ended September 30, 2021, we had a net loss of $19 which consists of formation costs.
For the nine months ended September 30, 2022, we had a net loss of $209,750, which consists of interest income from marketable securities held in the Trust Account of $43,907 and a gain on the change in fair value of the overallotment option of $7,619 offset by operating costs of $261,429. In addition, the Company recorded an income tax provision of $9,243. For the nine months ended September 30, 2021, we had a net loss of $78 which consists of formation costs.
Going Concern Considerations, Liquidity and Capital Resources
On September 22, 2022, the Company consummated its initial public offering (the “IPO”) of 8,000,000 units (the “Units”). Each Unit consists of one share of Class A common stock of the Company, par value $0.0001 per share (“Class A Common Stock”), one redeemable warrant of the Company (“Warrant”), with each whole Warrant entitling the holder thereof to purchase one share of Class A Common Stock for $11.50 per share, and one Right, with each Right entitling the holder to receive one-tenth of one share of Class A Common Stock. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $80,000,000.
Simultaneously with the consummation of the closing of the Offering, the Company consummated the private placement of an aggregate of 456,225 units (the “Private Placement Units”) to Global Star Acquisition I LLC, the sponsor of the Company (the “Sponsor”), at a price of $10.00 per Private Placement Unit, generating total gross proceeds of $4,563,000 (the “Private Placement”).
Subsequently, on October 4, 2022, the Company consummated the closing of the sale of 1,200,000 additional units at a price of $10 per unit (the “Units”) upon receiving notice of the underwriters’ election to exercise their overallotment option (“Overallotment Units”), generating additional gross proceeds of $12.0 million and incurred additional offering costs of $412,500, of which $262,500 are for deferred underwriting commissions. Each Unit consists of one share of Class A common stock of the Company, par value $0.0001 per share (“Class A Common Stock”), one-half of one Class A redeemable warrant of the Company (“Warrant”), with each whole Warrant entitling the holder thereof to purchase one share of Class A Common Stock for $11.50 per share, and one Right (“Right”), with each Right entitling the holder to receive one-tenth of one share of Class A Common Stock, subject to adjustment, pursuant to the Company’s registration statement on Form S-1 (File No. 333-266387).
Simultaneously with the exercise of the overallotment, the Company consummated the Private Placement of an additional 42,000 Private Placement Units to Global Star Acquisition I LLC, a Delaware limited liability company (the “Sponsor”), generating gross proceeds of $420,000.
Transaction costs of the Initial Public Offering with the exercise of the overallotment amounted to $4,595,311 consisting of $950,000 of cash underwriting fees, $3,062,500 of deferred underwriting fees and $582,811 of other costs.
As of September 30, 2022, we had available to us $1,397,490 of cash on our balance sheet and a working capital of $861,449. We intend to use the funds held outside of the Trust Account for identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the Business Combination. The interest income earned on the investments in the Trust Account are unavailable to fund operating expenses.
In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into additional Placement Units at a price of $10.00 per Unit. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As September 30, 2022, the Company has not borrowed under such loans.
21
Table of Contents
If the Company has not completed a Business Combination within 12 months from the closing of this offering (September 22, 2023 or up to 21 months from the closing of this offering at the election of the company in nine one month extensions subject to satisfaction of certain conditions, including the deposit of up to $264,000, or $303,600 if the underwriters’ over-allotment option is exercised in full ($0.033 per unit in either case) for the one month extension, into the trust account, or as extended by the company’s stockholders in accordance with our amended and restated certificate of incorporation), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.
As of September 30, 2022, the Company had investments held in the Trust Account of $82,043,907 principally invested in U.S. government securities. As of September 30, 2022, the Company had a working capital of approximately $861,400, current liabilities of approximately $820,000 and cash of approximately $1,397,500.
In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the Company does not have adequate liquidity to sustain operations and the possibility that the Company may be unsuccessful in consummating an initial business combination within 12 months (or up to 21 months from the closing of this offering at the election of the Company in nine one month extensions) from the closing of the Initial Public Offering, and thereby be required to cease all operations, redeem the public shares and thereafter liquidate and dissolve. In addition, there is no current commitment on the part of any financing source to provide additional capital and no assurances can be provided that such additional capital will ultimately be available. These conditions raise substantial doubt about the ability to continue as a going concern. The accompanying financial statement has been prepared in conformity with GAAP, which contemplate continuation of the Company as a going concern.
22
Table of Contents
Off-Balance Sheet Financing Arrangements
We have no obligations, assets or liabilities which would be considered off-balance sheet arrangements. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements.
We have not entered any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or entered any non-financial assets.
Contractual Obligations
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities. Commencing on the date of the prospectus and until completion of the Company’s Business Combination or liquidation, the Company may reimburse ARC Group Ltd., an affiliate of the Sponsor, up to an amount of $10,000 per month for office space, secretarial and administrative support.
The Underwriter was paid a cash underwriting fee of 2.0% of gross proceeds of the Public Offering, or $1,600,000 (less $800,000 reimbursed to the Company). In addition, the Underwriter is entitled to aggregate deferred underwriting commissions of $2,800,000 consisting of 3.5% of the gross proceeds of the Public Offering. The deferred underwriting commissions will become payable to the Underwriter from the amounts held in the Trust Account solely in the event that the Company completes an initial Business Combination, subject to the terms of the underwriting agreement.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Following the consummation of our Initial Public Offering, the net proceeds of our Initial Public Offering, including amounts in the Trust Account, have been invested in U.S. government treasury bills, notes or bonds with a maturity of 185 days or less or in certain money market funds that invest solely in US treasuries. Due to the short-term nature of these investments, we do not believe that there will be an associated material exposure to interest rate risk
23
Table of Contents
Item 4. Controls and Procedures
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer, to allow timely decisions regarding required disclosure.
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2022, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial and accounting officer have concluded that during the period covered by this report, our disclosure controls and procedures were not effective as of September 30, 2022, due to a material weakness in our internal control over financial reporting related to our accounting and reporting for the existence of our assets and corresponding income, as well as the accounting and reporting for the completeness and accuracy of our liabilities and the corresponding income and expense. In light of these material weaknesses, we performed additional analysis as deemed necessary to ensure that our condensed financial statements were prepared in accordance with GAAP. Accordingly, management believes that the condensed financial statements included in this Quarterly Report on Form 10-Q present fairly in all material respects our financial position, results of operations and cash flows for the period presented.
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected and corrected on a timely basis.
Effective internal controls are necessary for us to provide reliable financial reports and prevent fraud. We continue to evaluate steps to remediate the material weakness. These remediation measures may be time consuming and costly and there is no assurance that these initiatives will ultimately have the intended effects. We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Changes in Internal Control over Financial Reporting
During the most recently completed fiscal quarter ended September 30, 2022, there was no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
24
Table of Contents
PART II—OTHER INFORMATION
Item 1. Legal Proceedings
None.
Item 1A. Risk Factors
As of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in our final prospectus dated September 13, 2022 filed with the SEC, except we may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.
Risks Related to Taxes
New legislation that would change U.S. or foreign taxation of business activities could seriously harm our business, or the financial markets and the market price of our Class A common stock.
On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (H.R. 5376) (the “IRAct”), which, among other things, imposes a 1% excise tax on any domestic corporation that repurchases its stock after December 31, 2022 (the “Excise Tax”). The Excise Tax is imposed on the fair market value of the repurchased stock, with certain exceptions. While not free from doubt, absent any further guidance from the IRS or Congress, the Excise Tax may apply to any redemptions of our common stock after December 31, 2022, including redemptions in connection with a merger, unless an exemption is available. Except for franchise taxes and income taxes, we may be prohibited from using the proceeds placed in the Trust Account and the interest earned thereon to pay for fees or taxes that may be levied on the Company pursuant to any current, pending, or future rules or laws, including without limitation any excise tax due under the IRAct on any redemptions or stock buybacks by the Company.
Based on our preliminary assessment, we do not anticipate a material impact on our financial statements. Management will continue to assess the impact of the IRAct as additional guidance becomes available.
Item 2. Unregistered Sale of Equity Securities and Use of Proceeds.
Unregistered Sales of Equity Securities
On September 22, 2022, simultaneously with the consummation of the closing of the Offering, the Company consummated the private placement of an aggregate of 456,225 units (the “Private Placement Units”) to Global Star Acquisition I LLC, the sponsor of the Company (the “Sponsor”), at a price of $10.00 per Private Placement Unit, generating total gross proceeds of $4,563,000 (the “Private Placement”). Subsequently, on October 4, 2022, simultaneously with the exercise of the overallotment, the Company consummated the Private Placement of an additional 42,000 Private Placement Units to the Sponsor, generating gross proceeds of $420,000. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Units was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
25
Table of Contents
The placement warrants included in the placement units are identical to the warrants sold as part of the units in this offering except that, so long as they are held by our sponsor or its permitted transferees, (i) they will not be redeemable by us, (ii) they (including the Class A common stock issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of our initial business combination, (iii) they may be exercised by the holders on a cashless basis, and (iv) will be entitled to registration rights.
Use of Proceeds from the Public Offering
On September 22, 2022, the Company consummated its Initial Public Offering of 8,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $80,000,000, and incurring offering costs of $4,182,811, of which $2,800,000 was for deferred underwriting commissions.
Subsequently, on October 4, 2022, the Company consummated the closing of the sale of 1,200,000 additional units at a price of $10 per unit (the “Units”) upon receiving notice of the underwriters’ election to exercise their overallotment option (“Overallotment Units”), generating additional gross proceeds of $12.0 million and incurred additional offering costs, of which $262,500 are for deferred underwriting commissions of $412,500 in underwriting fees. Each Unit consists of one share of Class A common stock of the Company, par value $0.0001 per share (“Class A Common Stock”), one-half of one redeemable warrant of the Company (“Warrant”), with each whole Warrant entitling the holder thereof to purchase one share of Class A Common Stock for $11.50 per share, and one Right (“Right”), with each Right entitling the holder to receive one-tenth of one share of Class A Common Stock, subject to adjustment, pursuant to the Company’s registration statement on Form S-1 (File No. 333-266387).
The securities sold in the Public Offering were registered under the Securities Act on a registration statement on Form S-1 (No. 333266387). The SEC declared the registration statement effective on September 19, 2022.
Of the gross proceeds received from the Initial Public Offering and the Private Placement Units, $58,075,000 was placed in a Trust Account. We paid a total of $800,000 (2% fee of $1,600,000 less $800,000 reimbursed to the Company) in underwriting discounts and commissions and $582,811 for other costs and expenses related to the Initial Public Offering. In addition, the underwriters agreed to defer $2,800,000 in underwriting discounts and commission.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not Applicable
Item 5. Other Information
None.
26
Table of Contents
Item 6. Exhibits
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
Filed herewith.
Furnished.
To be filed by amendment.
27
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GLOBAL STAR ACQUISITION CORP. | ||||||
Date: December 6, 2022 | By: | /s/ Anthony Ang | ||||
Anthony Ang | ||||||
Chief Executive Officer | ||||||
Date: December 6, 2022 | By: | /s/ Shan Cui | ||||
Shan Cui | ||||||
Chief Financial Officer |
28